[1] |
GAO Rui, GUO Lei, PENG Bo, JIA Jun.
Expression of ALG2 in oral squamous cell carcinoma and its prognostic diagnostic value
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(5): 357-364.
|
[2] |
ZHAO Yuan, LÜ Jilian, YE Keqiang, LIN Nan, PEI Fei.
Serum levels of NGAL and YKL-40 in patients with oral squamous cell carcinoma and their diagnostic and prognostic value
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(5): 365-370.
|
[3] |
XIE Diya, XIAO Tao, SHAN Danni, ZHOU Ting, WANG Zhiyong.
Application and prospects of near-infrared fluorescence guided surgery in the treatment of oral cancer
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(4): 251-258.
|
[4] |
XIONG Jianzhe, ZHANG Hao, YU Wei.
Sorafenib tosylate inhibits autophagy, proliferation and migration of oral squamous cell carcinoma
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(4): 276-281.
|
[5] |
SUN Shuohui, LIU Qinyao, MA Junli, LI Xiao, WANG Zhifa.
Cervical malignant peripheral nerve sheath tumors: A case report and literature review
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(4): 314-318.
|
[6] |
YANG Qiong, YANG Xu, LI Yi, LIU Hualian, ZHU Zhichao, ZHENG Xiao, XU Tianshu.
Expression of co-stimulation molecule B7-H4 in oral tongue squamous cell carcinoma and its relationship to prognosis
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(3): 187-192.
|
[7] |
ZOU Xian, SONG Tao.
Bioinformatics analysis of potential targets influencing the prognosis of OSCC
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(3): 193-201.
|
[8] |
LI Jinwei, SHA Tong, ZHENG Kaijuan, NIE Mengdong, GUAN Weihang, SHI Ce.
Interpretation of the WHO 2022 classification of head and neck tumours (5th Edition): The epithelial tumours of oral cavity and mobile tongue
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(2): 81-86.
|
[9] |
LI Shaopeng, YANG Haiyan, ZHANG Li, PANG Zhenzhen.
Effect of resveratrol on chemotherapy resistance in cisplatin-induced OSCC cells through NF-κB related pathway
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(2): 94-99.
|
[10] |
WANG Jinhang, CUI Zifeng, YANG Kaicheng, CHEN Yanping, PENG Shixiong.
Expression and clinical significance of E2F transcription factor 1 in OSCC
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(2): 100-107.
|
[11] |
CHU Chen, XUE Yu, YAN Zhou, QIU Jianping, CHU Weiming.
Effect of depth of invasion of cT1N0M0 OSCC on predicting lymph node metastasis and assessing prognosis
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2024, 34(1): 40-44.
|
[12] |
WANG Jingxuan, LIU Hongyue, ZHUANG Zhizheng, HU Yan, YANG Yingshun.
Study on the mechanism of MMP-9 inhibitor on biological behavior of human oralsquamous cell carcinoma cell line CAL27
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2023, 33(6): 363-369.
|
[13] |
ZHANG Jin, CHENG Zheng, YAN Xiaojing, LEI Bing.
Construction and validation of risk prediction model for postoperative infection in OSCC patients after radical resection
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2023, 33(6): 385-390.
|
[14] |
MA Zhongkai, MA Pingchuan, ZHANG Gaowei, LI Honglin, LI Chunjie.
Parosteal lipoma of mandibular buccal vestibule: A case report
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2023, 33(6): 410-413.
|
[15] |
ZHOU Xinyi, YE Tao, QIU Fengmei.
miR-503 targeting RECK regulates the proliferation, invasion and apoptosis of oral squamous cells carcinoma cells
[J]. 《Journal of Oral and Maxillofacial Surgery》, 2023, 33(5): 305-313.
|